Latest News
News
Meta-analysis provides safety data on IL-17, IL-23 inhibitors
Infections, nasopharyngitis, and headaches were the most common complaints among patients on IL-17 or IL-23 inhibitors
News
Ultrasound improves specificity of psoriatic arthritis referrals
Adding ultrasound to screening questionnaires can improve screening for psoriatic arthritis in patients with psoriasis.
News
Evidence builds for effects of obesity, low physical activity on development of psoriatic arthritis
The study “adds to the growing evidence that the risk of PsA is modifiable and highlights the importance of preventive work against obesity as...
Conference Coverage
SPIRIT-H2H results confirm superiority of ixekizumab over adalimumab for PsA
ATLANTA – Biologic-naive patients with PsA responded better to ixekizumab than to adalimumab for skin and joint symptoms, and at least as well...
Conference Coverage
Expert shares tips for TNF-alpha inhibitor use in special populations
LAS VEGAS – Optimizing anti-TNF-alpha treatment starts with recognizing there is a loss of response over time, Dr. Kerdel said.
Conference Coverage
Guselkumab improves psoriatic arthritis regardless of prior TNFi use
ATLANTA – Guselkumab, an anti-IL-23p19 monoclonal antibody, showed efficacy versus placebo for active PsA in both biologic-naive and TNFi-treated...
Conference Coverage
Patients taking TNF inhibitors can safely receive Zostavax
ATLANTA – Investigators found no confirmed varicella infection cases at 6 weeks.
Latest News
Observational secukinumab data reflect clinical trial results in patients with moderate to severe psoriasis
A
Conference Coverage
No infection increase seen with biologics in older psoriasis patients
MADRID – “We really think that older patients should be offered treatments at the same level of disease control as all the rest of our psoriasis...
Conference Coverage
Serlopitant improves psoriatic itch in phase 2 study
MADRID –